This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Dementia is a syndrome characterised by a chronic or progressive brain disorder in which numerous higher cortical functions, such as memory, thinking, direction, understanding, computation, learning ability, language, and judgement, are disrupted. The state of consciousness is clear. Dementia primarily affects the elderly; just 2% of cases begin before the age of 65. After that, every five years of age increases the incidence by a factor of two. Dementia is one of the most common causes of later-life disability. In the elderly, neurodegenerative processes affect the brain, resulting in gradual, incapacitating cognitive, behavioral, and motor dysfunctions that eventually lead to dementia. The presence of neurological symptoms, which could act as early indicators of dementia and predictors of mortality, is likely to precede fully evident dementia.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of